Clinical Trials Directory

Trials / Completed

CompletedNCT01119885

Observational Study Investigating the Effectiveness of Fentanyl Matrix in Relieving Pain and Improving Function in Patients With Osteoarthritis of the Knee or Hip

Fentanyl Matrix for the Treatment of Pain Caused by Osteoarthritis of the Knee or Hip: Improvement of Pain and Function: Multicenter, Open-label, Prospective, Observational Study

Status
Completed
Phase
Study type
Observational
Enrollment
742 (actual)
Sponsor
Janssen Korea, Ltd., Korea · Industry
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate the utility of fentanyl matrix for the treatment of pain due to osteoarthritis (OA) of knee or hip, which was not adequately controlled by non-opioid analgesic (e.g. NSAIDs or COX-II inhibitors) or weak opioids \[tramadol HClacetaminophen, tramadol or codeine (or combinations with acetaminophen/ibuprofen)\].

Detailed description

This study is a prospective, open-label, non-interventional study. The objective of this study is to investigate the utility of fentanyl matrix after 8 week treatment of fentanyl matrix for the treatment of pain due to osteoarthritis (OA) of knee or hip, which was not adequately controlled by non-opioid analgesic (e.g. NSAIDs or COX-II selective inhibitors) or weak opioids \[tramadol HCl with acetaminophen, tramadol or codeine (or combination with acetaminophen/ibuprofen)\] in clinical practice according to the investigator's discretion. This study will investigate the usefulness of fentanyl matrix based on improvement in pain and function after Fentanyl matrix administration in patients who complained of pain caused by osteoarthritis and indicated for Fentanyl matrix administration in clinical practice at the investigator's discretion. This study will also measure the patients' functional improvement through Korean Version of WOMAC. Observational study - No investigational drug administered

Conditions

Interventions

TypeNameDescription
DRUGfentanyl matrixKnee osteoarthritis, starting with 12mcg/h (flexible dose)
DRUGfentanyl matrixHip osteoarthritis, starting with 12mcg/h (flexible dose)

Timeline

Start date
2008-08-01
Primary completion
2009-01-01
Completion
2009-01-01
First posted
2010-05-10
Last updated
2014-04-28

Source: ClinicalTrials.gov record NCT01119885. Inclusion in this directory is not an endorsement.